10-Q Filing

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC CIK: 1730430 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001558370-20-009147`
Period End Date	20200630
Filing Date	20200804
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	knsa-20200630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 49 Income Statement 62 Cash Flow Statement 56 Stockholders Equity 34

Balance Sheet 49 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$123.46M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.93M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$128.94M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$186.45M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.25M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$12.10M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$264.49M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$241.63M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.40M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.21M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$1.93M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$1.32M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$210.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$210.00K	USD	Point-in-time
Deferred offering costs	`DeferredCosts`	$205.00K	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$4.37M	USD	Point-in-time
Total assets	`Assets`	$271.44M	USD	Point-in-time
Total assets	`Assets`	$254.53M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.69M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.37M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$16.50M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$20.41M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.68M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.70M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$25.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$27.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$20.55M	USD	Point-in-time
Non-current operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$955.00K	USD	Point-in-time
Non-current operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$139.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$334.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$326.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$29.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$21.02M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$670.37M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$581.47M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$9.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$33.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-356.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-419.98M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$279.27M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$306.52M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$250.42M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$225.42M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$275.20M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$205.83M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$271.44M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$254.53M	USD	Point-in-time

Income Statement 62 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$30.85M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$22.32M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$43.23M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$90.10M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$9.54M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$16.84M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$18.02M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.44M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$31.86M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$61.25M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$106.94M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$39.29M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-61.25M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-106.94M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-39.29M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-31.86M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.05M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$266.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$3.53M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.72M	USD	1 Quarter
Loss before (provision) benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-60.19M	USD	2 Qtrs
Loss before (provision) benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-103.40M	USD	2 Qtrs
Loss before (provision) benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-37.56M	USD	1 Quarter
Loss before (provision) benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-31.59M	USD	1 Quarter
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$5.88M	USD	1 Quarter
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$-391.00K	USD	2 Qtrs
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$3.70M	USD	2 Qtrs
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$-374.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-63.89M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-103.01M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-26.42M	USD	1 Quarter
Net loss per share attributable to common shareholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.13	USD	2 Qtrs
Net loss per share attributable to common shareholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.68	USD	1 Quarter
Net loss per share attributable to common shareholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.65	USD	1 Quarter
Net loss per share attributable to common shareholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.94	USD	2 Qtrs
Weighted average common shares outstanding-basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	57.91M	shares	1 Quarter
Weighted average common shares outstanding-basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	56.62M	shares	2 Qtrs
Weighted average common shares outstanding-basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	53.23M	shares	2 Qtrs
Weighted average common shares outstanding-basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	54.48M	shares	1 Quarter
Net loss	`NetIncomeLoss`	$-37.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-103.01M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-63.89M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-26.42M	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-24.00K	USD	2 Qtrs
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$105.00K	USD	2 Qtrs
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$12.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$93.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-231.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$207.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-24.00K	USD	2 Qtrs
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-231.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$93.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$105.00K	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-37.10M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-63.91M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-102.91M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-37.70M	USD	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-103.01M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-63.89M	USD	2 Qtrs
Depreciation expense	`Depreciation`	$595.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$508.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.19M	USD	2 Qtrs
Depreciation expense	`Depreciation`	$979.00K	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$6.36M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$9.06M	USD	2 Qtrs
Class A common shares issued or to be issued as consideration for Primatope, including milestone payments	`IssuanceOfStockForAcquisition`	$8.80M	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$635.00K	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$603.00K	USD	2 Qtrs
Accretion of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$2.06M	USD	2 Qtrs
Accretion of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$313.00K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.39M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$4.37M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.64M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.84M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.66M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.23M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.72M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-4.15M	USD	2 Qtrs
Accrued milestones	`IncreaseDecreaseInAccruedMilestone`	$-15.00M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-602.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-833.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$943.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$7.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-104.93M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-61.02M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$223.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$767.00K	USD	2 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$273.49M	USD	2 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$133.95M	USD	2 Qtrs
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$191.75M	USD	2 Qtrs
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$306.34M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$57.57M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$32.09M	USD	2 Qtrs
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$569.00K	USD	2 Qtrs
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$118.00K	USD	2 Qtrs
Proceeds from exercise of options and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$693.00K	USD	2 Qtrs
Proceeds from exercise of options and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$5.35M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$79.97M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$83.68M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$76.53M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$10.83M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.14M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.19M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$123.67M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$83.02M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.14M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.19M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$123.67M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$83.02M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$1.03M	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$282.00K	USD	2 Qtrs
Deferred offering costs included in accrued expenses and accounts payable	`DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable`	$335.00K	USD	2 Qtrs
Property and equipment included in accrued expenses and accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$253.00K	USD	2 Qtrs

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of the period	`StockholdersEquity`	$279.27M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$306.52M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$250.42M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$225.42M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$275.20M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$205.83M	USD	Point-in-time
Common shares issued or to be issued in connection with the acquisition of all issued and outstanding equity securities of Primatope Therapeutics, Inc.	`StockIssuedDuringPeriodValueAcquisitions`	$7.00M	USD	1 Quarter
Common shares issued or to be issued in connection with a milestone payment due to Primatope Therapeutics, Inc.	`StockIssuedDuringPeriodValueMilestonePayments`	$1.80M	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$181.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.41M	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.94M	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$512.00K	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.89M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.85M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.46M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.21M	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$12.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-24.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$105.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-231.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$93.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$207.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-103.01M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-63.89M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-37.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.47M	USD	1 Quarter
Balance at the end of the period	`StockholdersEquity`	$275.20M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$279.27M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$306.52M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$250.42M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$225.42M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$205.83M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.